|
Volumn 39, Issue 8, 2012, Pages 730-731
|
Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
CYCLOSPORIN;
ETRETIN;
INFLIXIMAB;
METHOTREXATE;
USTEKINUMAB;
ADULT;
CASE REPORT;
CORTICOSTEROID THERAPY;
DRUG EFFICACY;
DRUG TREATMENT FAILURE;
ERYTHRODERMIC PSORIASIS;
HUMAN;
LETTER;
MALE;
MONOTHERAPY;
PSORIASIS SEVERITY INDEX;
TOPICAL TREATMENT;
TREATMENT RESPONSE;
ANTIBODIES, MONOCLONAL;
DERMATITIS, EXFOLIATIVE;
DERMATOLOGIC AGENTS;
HUMANS;
MALE;
MIDDLE AGED;
PSORIASIS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 84864415913
PISSN: 03852407
EISSN: 13468138
Source Type: Journal
DOI: 10.1111/j.1346-8138.2011.01499.x Document Type: Letter |
Times cited : (23)
|
References (5)
|